AngelMD hires Raymer as chief strategy officer


AngelMD, an investment and networking platform connecting medical startups, physicians, investors and industry partners, has appointed Michael Raymer as chief strategy officer. Raymer’s work background includes leadership roles at various companies such as Microsoft where he played a key role in launching its consumer health platform and ecosystem HealthVault.

PRESS RELEASE

SEATTLE, Feb. 2, 2018 – AngelMD announced that it has added Michael Raymer as Chief Strategy Officer. In this role, Raymer will be responsible for the planning, organization and execution of product strategies that are critical to AngelMD’s continued growth and success.

Raymer joins the company after having held global leadership positions across healthcare, information technology, medical devices and therapeutic diagnostics companies. He played an integral part at Microsoft for the company’s launch of its consumer health platform and ecosystem, branded HealthVault. He was also instrumental in the company’s launch of the Amalga suite of products for health systems and life science corporations.

“I have known Mike for a number of years and feel very fortunate to have an executive of his caliber joining our team at this enormous inflection point,” said AngelMD CEO Tobin Arthur. “Mike is one of the sharpest strategists and operators I know and he instantly raises the bar everywhere he goes.”

Outside of the Fortune 15, Raymer has had notable successes in leading startup organizations from the earliest points of product idea through to profitable operations. He has also led the turnaround strategy for two publicly-traded companies, culminating in successful exits for both.

“I ran global strategy for GE and Microsoft and what I saw was a disconnect,” said Raymer. “What physicians really believe in adds value to the healthcare system, but it was not a role that they played from an investment standpoint. I think what the beauty of AngelMD is that they’ve created a network of physicians that could give feedback specific to a specialty and the efficacy of an idea, whether that is a medical device, digital health, or pharma product.”

Raymer’s joining follows a streak of notable milestones for AngelMD in 2017 and the start of 2018. AngelMD syndicates have facilitated physician-led investments in numerous startups from around the world, and its Catalyst I LP fund has allowed AngelMD to inject capital directly into the successful future of many other companies. Alpha, the company’s inaugural healthcare innovation conference held in Napa, California, was lauded by attendees as “the best event” many had attended, and “essential” to investors and physicians who are looking to expand their reach into healthcare innovation.

About AngelMD
AngelMD is an investment and networking platform connecting medical startups, physicians, investors, and industry partners. Leading physicians from all over the US have joined AngelMD to help source, evaluate, and advise companies in the specialties of biotechnology, medical device, and healthcare technology. For more information, visit http://www.angelmd.co.

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.